Literature DB >> 7099207

Effect of the haptoglobin phenotype on the size of a myocardial infarct.

J P Chapelle, A Albert, J P Smeets, C Heusghem, H E Kulbertus.   

Abstract

We investigated the relation between haptoglobin (Hp) phenotypes and serum levels of various biochemical markers after myocardial infarction in 496 patients. In 122 subjects selected on the basis of short delays until hospitalization, patients with Hp 2-2 had higher cumulated creatine kinase activity than patients with Hp 1-1, or Hp 2-1 (P less than 0.05), as well as higher myoglobin concentrations (P less than 0.02) 12 to 28 hours after admission. Comparison of serum enzyme activities in the remaining 374 patients confirmed that Hp 2-2 patients had significantly higher total creatine kinase, creatine kinase isoenzyme MB fraction, aspartate aminotransferase, and lactate dehydrogenase peak levels. Complications of left ventricular failure were more frequent in these patients (P = 0.05). Our results suggest that Hp 2-2 patients have more severe myocardial infarctions than Hp 1-1 and Hp 2-1 patients, However, no difference in the distribution of haptoglobin phenotype was found between patients who had a myocardial infarction and healthy subjects, indicating that Hp 2-2 does not predispose to the occurrence of infarction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7099207     DOI: 10.1056/NEJM198208193070801

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  13 in total

1.  Haptoglobin polymorphism and association with complications in ghanaian type 2 diabetic patients.

Authors:  Michael B Adinortey; Ben A Gyan; Jonathan P Adjimani; Philomena E Nyarko; Charity Sarpong; Francis Y Tsikata; Alexander K Nyarko
Journal:  Indian J Clin Biochem       Date:  2011-05-13

Review 2.  Correlation of geographic distributions of haptoglobin alleles with prevalence of multiple sclerosis (MS) - a narrative literature review.

Authors:  Vladimir V Bamm; Arielle M Geist; George Harauz
Journal:  Metab Brain Dis       Date:  2016-11-02       Impact factor: 3.584

3.  Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis.

Authors:  M C Cid; D S Grant; G S Hoffman; R Auerbach; A S Fauci; H K Kleinman
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

4.  Biological activity of nitric oxide in the plasmatic compartment.

Authors:  Xunde Wang; Jose E Tanus-Santos; Christopher D Reiter; Andre Dejam; Sruti Shiva; Reginald D Smith; Neil Hogg; Mark T Gladwin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-16       Impact factor: 11.205

5.  Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation.

Authors:  Joseph McGuirk; Gang Hao; Weijian Hou; Sunil Abhyankar; Casey Williams; Weisi Yan; Jianda Yuan; Xiuqin Guan; Robert Belt; Shaun Dejarnette; Jeffery Wieman; Ying Yan
Journal:  J Hematol Oncol       Date:  2009-04-20       Impact factor: 17.388

6.  Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin.

Authors:  Leah E Cahill; Andrew P Levy; Stephanie E Chiuve; Majken K Jensen; Hong Wang; Nawar M Shara; Shany Blum; Barbara V Howard; Jennifer K Pai; Kenneth J Mukamal; Kathryn M Rexrode; Eric B Rimm
Journal:  J Am Coll Cardiol       Date:  2013-01-09       Impact factor: 24.094

7.  Haptoglobin: A major susceptibility gene for diabetic vascular complications.

Authors:  Tal Szafranek; Stuart Marsh; Andrew P Levy
Journal:  Exp Clin Cardiol       Date:  2002

Review 8.  Inflammatory triggers of acute rejection of organ allografts.

Authors:  Daniel N Mori; Daniel Kreisel; James N Fullerton; Derek W Gilroy; Daniel R Goldstein
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

Review 9.  Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus.

Authors:  Erik A Korte; Patrick M Gaffney; David W Powell
Journal:  Arthritis Res Ther       Date:  2012-02-20       Impact factor: 5.156

10.  Haptoglobin genotype and risk markers of cardiovascular disease in patients with chronic kidney disease.

Authors:  Charlotte Strandhave; My Svensson; Henrik Krarup; Jeppe Hagstrup Christensen
Journal:  Int J Nephrol       Date:  2013-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.